The analysis plots revealed that higher mRNA expression of MAP1A/1S was significantly correlated with shorter OS of NSCLC patients, while that of MAP2/4/6/7/7D3 was just the opposite (Figure 5). The gene discussed is MAP2; the disease is non-small cell lung carcinoma.